A. Erçalışkan

Therapy‐related chronic myeloid leukemia in a patient receiving peptide receptor radionuclide therapy for pancreatic neuroendocrine tumor

L. Kabasakal, A. E. Eşkazan, Selin Kucukyurt, 2020, Cancer reports.

The impact of BCR‐ABL1 transcript type on tyrosine kinase inhibitor responses and outcomes in patients with chronic myeloid leukemia

A. E. Eşkazan, A. Erçalışkan, 2018, Cancer.

Current evidence on the efficacy and safety of generic imatinib in CML and the impact of generics on health care costs.

A. E. Eşkazan, A. Erçalışkan, Duygu Seyhan Erdoğan, 2021, Blood advances.

Bosutinib - an effective and safe treatment option in the management of chronic myeloid leukemia.

A. E. Eşkazan, A. Erçalışkan, 2020, Future oncology.

Diagnosis and Management of Classical Hodgkin Lymphoma During the COVID-19 Pandemic

A. Salihoglu, Z. Başlar, A. E. Eşkazan, 2022, Current Problems in Cancer.

Giant Cell Arteritis with Concomitant Chronic Myelomonocytic Leukemia

S. Uğurlu, A. E. Eşkazan, Ş. Batur, 2020, Turkish journal of haematology : official journal of Turkish Society of Haematology.

The Real-Life Data on the Outcome of Hepatitis B Infection in Patients with B-Cell Lymphoproliferative Neoplasms Treated with Ibrutinib

A. Salihoglu, D. Keskin, A. E. Eşkazan, 2019, Blood.

Successful Management of Ibrutinib-Induced Thrombocytopenia with Eltrombopag in a Patient with Waldenström Macroglobulinemia

A. E. Eşkazan, A. Erçalışkan, Fatma Zehra Avcı, 2022, Turkish journal of haematology : official journal of Turkish Society of Haematology.

Metachronous Rectum Metastases from Gastric Adenocarcinoma: A Case Report

Feray Günver, D. Tural, E. Büyükünal, 2012, Case reports in medicine.